• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物在对抗卵巢癌方面的最新进展

Latest Advancements of Natural Products in Combating Ovarian Cancer.

作者信息

Lu Yangyuxiao, Huang Hong, Chen Yuling, He Keren, Fang Mengqi, Xu Ye, Zhou Yuan, Tao Fangfang

机构信息

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.

School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

J Cancer. 2025 Jul 28;16(11):3497-3512. doi: 10.7150/jca.118209. eCollection 2025.

DOI:10.7150/jca.118209
PMID:40861811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12374947/
Abstract

Ovarian cancer (OC), the seventh most common cancer in women globally, is one of the most prevalent and lethal gynecological cancers. With a high degree of malignancy and a dismal prognosis, late-stage patients frequently experience relapses and metastases. Associated with this is the high drug resistance of OC, which is a common challenge in cancer treatment. Natural products have garnered increasing attention in tumor treatment due to their relatively high safety and stable sources. Previous studies have demonstrated that various active ingredients in natural products can impact the progression of OC through diverse molecular mechanisms. These mechanisms include inducing cell cycle arrest, regulating reactive oxygen species (ROS), modulating autophagy, promoting cell apoptosis, inhibiting proliferation, invasion, and migration of OC cells, and regulating the tumor immune microenvironment (TIME). This article comprehensively elucidates the mechanisms by which natural products combat ovarian cancer and highlights both the emerging opportunities and existing challenges in their development as effective therapeutic agents.

摘要

卵巢癌(OC)是全球女性中第七大常见癌症,是最普遍且致命的妇科癌症之一。其恶性程度高,预后不佳,晚期患者常出现复发和转移。与此相关的是OC的高耐药性,这是癌症治疗中的一个常见挑战。天然产物因其相对较高的安全性和稳定的来源,在肿瘤治疗中受到越来越多的关注。先前的研究表明,天然产物中的各种活性成分可通过多种分子机制影响OC的进展。这些机制包括诱导细胞周期停滞、调节活性氧(ROS)、调节自噬、促进细胞凋亡、抑制OC细胞的增殖、侵袭和迁移,以及调节肿瘤免疫微环境(TIME)。本文全面阐明了天然产物对抗卵巢癌的机制,并强调了其作为有效治疗药物开发中出现的机遇和现有挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/12374947/be04290e9313/jcav16p3497g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/12374947/893cfd959d07/jcav16p3497g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/12374947/be04290e9313/jcav16p3497g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/12374947/893cfd959d07/jcav16p3497g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/12374947/be04290e9313/jcav16p3497g002.jpg

相似文献

1
Latest Advancements of Natural Products in Combating Ovarian Cancer.天然产物在对抗卵巢癌方面的最新进展
J Cancer. 2025 Jul 28;16(11):3497-3512. doi: 10.7150/jca.118209. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review.PARP 抑制剂在卵巢上皮性癌中的作用机制、疗效及临床意义的分子机制:系统评价。
Int J Mol Sci. 2022 Jul 23;23(15):8125. doi: 10.3390/ijms23158125.
6
Knowledge graph and bibliometric analysis of inflammatory indicators in ovarian cancer.卵巢癌炎症指标的知识图谱与文献计量分析
Front Oncol. 2025 Jun 30;15:1533537. doi: 10.3389/fonc.2025.1533537. eCollection 2025.
7
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients.从原发性肿瘤和患者来源的异种移植肿瘤建立的类器官模型反映了卵巢癌患者的铂敏感性。
bioRxiv. 2025 May 2:2024.06.28.601283. doi: 10.1101/2024.06.28.601283.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Electrophoresis电泳
10
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance.前列腺癌中的天然产物和长链非编码RNA:对病因学和治疗耐药性的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 18. doi: 10.1007/s00210-024-03736-x.

本文引用的文献

1
Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages.姜黄素通过调节肿瘤相关巨噬细胞抑制卵巢癌的恶性行为。
Med Oncol. 2025 Apr 5;42(5):151. doi: 10.1007/s12032-025-02682-9.
2
Curcumin induces mitochondrial dysfunction-associated oxidative DNA damage in ovarian cancer cells.姜黄素可诱导卵巢癌细胞中线粒体功能障碍相关的氧化性DNA损伤。
PLoS One. 2025 Mar 31;20(3):e0319846. doi: 10.1371/journal.pone.0319846. eCollection 2025.
3
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.
乳腺癌和卵巢癌中的TP53突变与MDM2多态性:药物和天然化合物的改善作用
Clin Transl Oncol. 2025 Jan 11. doi: 10.1007/s12094-024-03841-6.
4
Innovative nanocarrier systems for enhanced delivery of phyto-active compounds in cancer therapy.用于癌症治疗中增强植物活性化合物递送的创新纳米载体系统。
Nanomedicine (Lond). 2025 Jan;20(1):91-116. doi: 10.1080/17435889.2024.2440301. Epub 2024 Dec 20.
5
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors.靶向 GPX4 介导的铁死亡保护使 BRCA1 缺陷型癌细胞对 PARP 抑制剂敏感。
Redox Biol. 2024 Oct;76:103350. doi: 10.1016/j.redox.2024.103350. Epub 2024 Sep 11.
6
Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential.白藜芦醇在妇科癌症治疗中的作用机制及治疗潜力
Curr Med Chem. 2024 May 3. doi: 10.2174/0109298673290941240430171146.
7
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
8
Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.姜黄素通过抑制 PI3K-AKT/STAT3 信号通路抑制 M2 型巨噬细胞来源的紫杉醇耐药性。
Anticancer Agents Med Chem. 2024;24(2):146-156. doi: 10.2174/0118715206275259231105184959.
9
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition.细胞周期蛋白依赖性激酶(CDK)4/6在卵巢组织中的作用及其外源性抑制的可能影响。
Cancers (Basel). 2023 Oct 10;15(20):4923. doi: 10.3390/cancers15204923.
10
Baicalein suppresses HER2-mediated malignant transformation of HER2-overexpressing ovarian cancer cells by downregulating HER2 gene expression.黄芩素通过下调 HER2 基因表达抑制 HER2 过表达卵巢癌细胞的 HER2 介导的恶性转化。
Environ Toxicol. 2023 Jul;38(7):1609-1617. doi: 10.1002/tox.23790. Epub 2023 Mar 29.